Augusta University/University of Georgia Medical Partnership, Athens, GA, USA.
University Vascular, Watkinsville, GA, USA.
Vasc Endovascular Surg. 2023 Aug;57(6):626-638. doi: 10.1177/15385744231163964. Epub 2023 Mar 15.
Iatrogenic injury to the large abdominopelvic veins can he highly morbid, and open surgical repair is technically challenging. Endovascular repair with covered stenting across the injured segment offers an alternative to open surgical management. We present a series of patients with operative injury to the inferior vena cava (IVC) and iliac veins who were treated utilizing an endovascular approach and review the available literature on this technique.
A PubMed keyword and MeSH term search was performed, and titles were reviewed for relevance by the first author. Studies related to endovascular repair of iatrogenic injury to the IVC and iliac veins were then read in detail for possible inclusion in the review. Those deemed appropriate were further analyzed for interventional approach, stent type and size, technical success, post-procedural pharmacologic management, complications and surveillance strategy.
The initial search resulted in 6221 publications. A total of 17 met criteria for inclusion, all of which were case reports or series. Twenty-six patients were described as suffering iatrogenic injury to the IVC or iliac veins, treated with various types and sizes of stents. All cases achieved technical success with hemorrhage control. Procedural complications occurred in 15.4% of cases, including 3 cases of acute thrombus formation and 1 case of stenosis caudal to the initial stent edge requiring additional stenting. Two additional patients experienced stent occlusion in the surveillance period.
Endovascular repair of iatrogenic injury to the IVC and iliac veins can be an effective management option. However, due to limited data regarding this approach, many technical questions remain, including ideal size and type of stent graft, necessity and duration of post-procedural anticoagulant or antiplatelet therapy and appropriate surveillance. Additionally, long term outcomes in this population have not yet been described.
医源性大腹盆腔静脉损伤可能导致严重的并发症,而开放手术修复具有一定的技术挑战性。经血管内覆膜支架跨越损伤段修复是开放手术治疗的替代方法。我们报告了一系列因手术损伤下腔静脉(IVC)和髂静脉而采用血管内方法治疗的患者,并回顾了关于该技术的现有文献。
进行了 PubMed 关键字和 MeSH 术语搜索,并由第一作者对标题进行了相关性审查。然后详细阅读了与 IVC 和髂静脉医源性损伤的血管内修复相关的研究,以确定是否可能纳入综述。认为合适的研究进一步分析了介入方法、支架类型和尺寸、技术成功率、术后药物管理、并发症和监测策略。
最初的搜索产生了 6221 篇出版物。共有 17 项符合纳入标准,均为病例报告或系列研究。26 例患者被描述为 IVC 或髂静脉医源性损伤,采用各种类型和尺寸的支架治疗。所有病例均实现了技术成功,出血得到控制。15.4%的病例发生了程序并发症,包括 3 例急性血栓形成和 1 例初始支架边缘下游狭窄,需要额外支架置入。另外 2 例患者在监测期间发生支架闭塞。
血管内修复 IVC 和髂静脉医源性损伤可以是一种有效的治疗选择。然而,由于该方法的数据有限,许多技术问题仍然存在,包括理想的支架移植物的大小和类型、术后抗凝或抗血小板治疗的必要性和持续时间以及适当的监测。此外,该人群的长期结果尚未描述。